Home › Pharmacology › Augmentin: Mechanism, Pharmacokinetics and Clinical Uses

Augmentin

For medical students2 min readUpdated 2026-10-10

Augmentin is a combination antibacterial medication belonging to the beta-lactam antibiotic class (specifically, a $\beta$-lactamase inhibitor-protected penicillin). It consists of a broad-spectrum semisynthetic penicillin combined with an enzyme inhibitor, allowing it to successfully overcome bacterial resistance.

FormulationsTablets (0.875/0.125 g; 0.5/0.125 g; 0.25/0.125 g)

CompositionAmoxicillin + Clavulanic Acid

Spectrum of ActivityH. influenzae, S. pneumoniae, H. pylori

AdministrationOral (*per os*), 2–3 times daily with meals

Mechanism of Action

Augmentin is a fixed-dose combination of an antibiotic and an enzyme inhibitor. The primary limitation of monotherapy with broad-spectrum semisynthetic penicillins (such as amoxicillin) is their rapid degradation by specific bacterial enzymes—$\beta$-lactamases (penicillinases).

To overcome this resistance, clavulanic acid is added to the formulation. Chemically, it also contains a $\beta$-lactam ring and exhibits very weak intrinsic antibacterial activity. Its primary pharmacological role is different: clavulanic acid binds to bacterial $\beta$-lactamases and irreversibly inactivates them. This prevents the hydrolysis of the primary antibiotic, allowing amoxicillin to unhinderedly disrupt cell wall synthesis and destroy pathogens.

Pharmacokinetics

The pharmacokinetic profile of the drug is largely determined by the properties of amoxicillin, which offers significant advantages over its predecessor, ampicillin.

Absorption: Absorbed 2 to 2.5 times better than ampicillin. Bioavailability reaches 90–95%.
Food Effect: Unlike ampicillin, whose absorption is decreased by food intake, amoxicillin absorption is not impaired by food, maintaining stable plasma concentrations. Nevertheless, standard prescribing guidelines recommend taking Augmentin tablets with meals.
Gastrointestinal Distribution: Because the drug is absorbed very efficiently in the upper gastrointestinal tract, extremely low concentrations reach the lower GI tract.
Route of Administration: The tablet formulation is administered exclusively orally (per os).

Indications for Use

The spectrum of activity of this protected penicillin is significantly expanded due to the suppression of bacterial enzymes. The drug is indicated for infections caused by the following pathogens:

Haemophilus influenzae (causes pneumonia, meningitis).
Streptococcus pneumoniae (including strains resistant to natural penicillins).
Helicobacter pylori (amoxicillin demonstrates high activity against this pathogen).

Limitations and Clinical Considerations

It is critical to understand when this medication should not be used. Due to its pharmacokinetic profile (extremely low concentrations in the lower gastrointestinal tract), Augmentin is not used to treat enteric infections such as salmonellosis or shigellosis. Furthermore, it has inherently lower activity against bacteria of the genus Shigella.

For comparison: enteric infections are more commonly treated with ampicillin, which is incompletely absorbed (only 30–40%) and thereby achieves high therapeutic concentrations directly within the intestinal lumen.

Prescribing Guide: Dosages

The drug is available as tablets containing a fixed ratio of active ingredients (amoxicillin/clavulanic acid). Dosage is selected based on the severity of the infection and the required dosing frequency:

0.250/0.125 g tablets — administered orally 3 times daily.
0.5/0.125 g tablets — administered orally 2–3 times daily.
0.875/0.125 g tablets — administered orally 2 times daily.

Mandatory condition: all oral formulations should be taken with meals.

Mnemonic

Augmentin = Amoxicillin (Attacks the bacterium) + Clavulanic Acid (Covers against enzymes).

Frequently asked questions

What adverse effects are associated with Augmentin?

Augmentin therapy may be accompanied by adverse reactions involving the digestive, hepatobiliary, and immune systems.

Gastrointestinal disorders — nausea, vomiting, decreased appetite, and diarrhea (up to the development of Clostridium difficile-associated colitis).
Immunoallergic reactions — rash, fever, facial edema, lymphadenopathy, and eosinophilia.
Severe cutaneous adverse reactions — Stevens-Johnson syndrome and toxic epidermal necrolysis (Lyell syndrome).
Hepatotoxicity — vanishing bile duct syndrome, characterized by persistent elevations in alkaline phosphatase and bilirubin, ductopenia, fibrosis, and potential progression to hepatic failure.

Why is clavulanic acid added to the formulation if it has weak antibacterial activity?

It acts as a bacterial enzyme inhibitor. By binding to $\beta$-lactamases, it irreversibly inactivates them and protects amoxicillin from degradation.

Why is Augmentin not prescribed for enteric infections (e.g., shigellosis)?

Due to high bioavailability (90–95%), the drug is almost completely absorbed in the upper GI tract. Its concentration in the lower bowel is too low to achieve a therapeutic effect.

Does the absorption of the drug depend on food intake?

The absorption of amoxicillin itself is not affected by food (unlike ampicillin); however, it is recommended to take Augmentin with meals to improve gastrointestinal tolerability.

What is the difference between the protection mechanism of Augmentin and Imipenem?

Augmentin is protected by clavulanic acid against bacterial $\beta$-lactamases. Imipenem (a carbapenem) is protected by cilastatin against degradation by a renal enzyme—dehydropeptidase I.

Go deeper

Comparative pharmacokinetics of ampicillin and amoxicillin.
Mechanism of bacterial resistance mediated by $\beta$-lactamase production.
Other inhibitor-protected penicillins: ampicillin + sulbactam (unasyn), piperacillin + tazobactam (tazocin).
Management of infections caused by Haemophilus influenzae and Streptococcus pneumoniae.
Differential selection of antibiotics for enteric infections (ciprofloxacin, ampicillin).